Effects of Soy Compounds on Breast Cancer, Prostate Cancer, and Bone Health

Completed · Phase 2

Conditions studied: Breast Cancer, Prostate Cancer

In brief

This study will determine the effects of soy products on in vitro surrogate cancer markers as well as bone density markers and quality of life parameters in men and women. This study will also determine concentrations of isoflavones (naturally occurring plant compounds that act like estrogen in the body) in prostate tissue that has been removed during prostatectomy, as well as in the blood.

Key facts

Study ID

NCT00200824

Run by

National Center for Complementary and Integrative Health (NCCIH)

Starts

2000-05-01

Expected to finish

2005-01-01

Last updated by the study team

2009-03-12

Who can join

Age: any. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Scheduled for prostatectomy
• Willing and able to consume study tablets for at least 2 weeks prior to surgery
• Willing to accept random assignment
• Signed informed consent

You may not qualify if…

• Unwilling to avoid soy intake during the study period
• Currently taking antibiotics

Where it is running

• Christopher Gardner — Stanford, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.